BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26768871)

  • 1. Application of the Enterprise Stent in Atherosclerotic Intracranial Arterial Stenosis: A Series of 60 Cases.
    Wang X; Wang Z; Wang C; Ji Y; Ding X; Zang Y
    Turk Neurosurg; 2016; 26(1):69-76. PubMed ID: 26768871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent.
    Vajda Z; Schmid E; Güthe T; Klötzsch C; Lindner A; Niehaus L; Sperber W; Peters J; Arnold G; Bäzner H; Henkes H
    Neurosurgery; 2012 Jan; 70(1):91-101; discussion 101. PubMed ID: 21778921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise.
    Salik AE; Selcuk HH; Zalov H; Kilinc F; Cirak M; Kara B
    Interv Neuroradiol; 2019 Oct; 25(5):484-490. PubMed ID: 30991867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases.
    Zhang K; Li TX; Wang ZL; Gao BL; Gu JJ; Gao HL; Wang YF; Xia JC
    Sci Rep; 2021 May; 11(1):10479. PubMed ID: 34006896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undersized angioplasty and stenting of symptomatic intracranial tight stenosis with Enterprise: Evaluation of clinical and vascular outcome.
    Lee KY; Chen DY; Hsu HL; Chen CJ; Tseng YC
    Interv Neuroradiol; 2016 Apr; 22(2):187-95. PubMed ID: 26542728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of enterprise stent use on the treatment of intracranial atherosclerosis disease.
    Ari O; Nas OF; Inecikli MF; Hakyemez B
    Neuroradiol J; 2022 Oct; 35(5):612-618. PubMed ID: 35392732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic intracranial vertebral artery atherosclerotic stenosis (≥70%) with concurrent contralateral vertebral atherosclerotic diseases in 88 patients treated with the intracranial stenting.
    Wang ZL; Gao BL; Li TX; Cai DY; Zhu LF; Bai WX; Xue JY; Li ZS
    Eur J Radiol; 2015 Sep; 84(9):1801-4. PubMed ID: 26119803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term outcome of stenting with Enterprise stents for symptomatic intracranial atherosclerotic disease at a single center.
    Li A; Ye Z; Zhou W; Qin C
    Interv Neuroradiol; 2023 Dec; 29(6):731-737. PubMed ID: 36259331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A long-term follow-up results of Enterprise stent in treatment of severe symptomatic basilar artery atherosclerotic stenosis].
    Zhao Y; Jin M; Liu Q; Liu D; Chen J; Du B
    Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):372-6. PubMed ID: 27143187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular treatment of symptomatic intracranial stenosis with the Wingspan stent system and Gateway PTA balloon: a multicenter series of 60 patients with acute and midterm results.
    Costalat V; Maldonado IL; Vendrell JF; Riquelme C; Machi P; Arteaga C; Turjman F; Desal H; Sedat J; Bonafé A
    J Neurosurg; 2011 Oct; 115(4):686-93. PubMed ID: 21740123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitaire stents for the treatment of complex symptomatic intracranial stenosis after antithrombotic failure: safety and efficacy evaluation.
    Duan G; Feng Z; Zhang L; Zhang P; Chen L; Hong B; Xu Y; Zhao W; Liu J; Huang Q
    J Neurointerv Surg; 2016 Jul; 8(7):680-4. PubMed ID: 26041096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recanalization results after intracranial stenting of atherosclerotic stenoses.
    Blasel S; Yükzek Z; Kurre W; Berkefeld J; Neumann-Haefelin T; Hattingen E; du Mesnil de Rochemont R
    Cardiovasc Intervent Radiol; 2010 Oct; 33(5):914-20. PubMed ID: 19908087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of enterprise stenting for symptomatic atherosclerotic severe posterior circulation stenosis.
    Zhou ZL; Li TX; Zhu LF; Wu LH; Guan M; Ma ZK; Liu YH; Qin J; Gao BL
    Eur J Med Res; 2023 Aug; 28(1):286. PubMed ID: 37592323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of branch arteries after intracranial stenting.
    Lopes DK; Ringer AJ; Boulos AS; Qureshi AI; Lieber BB; Guterman LR; Hopkins LN
    Neurosurgery; 2003 Jun; 52(6):1275-8; discussion 1278-9. PubMed ID: 12762872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent placement for atherosclerotic stenosis of the vertebral artery ostium: angiographic and clinical outcomes in 117 consecutive patients.
    Hatano T; Tsukahara T; Miyakoshi A; Arai D; Yamaguchi S; Murakami M
    Neurosurgery; 2011 Jan; 68(1):108-16; discussion 116. PubMed ID: 21099720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Wingspan Stenting for Severe Symptomatic Atherosclerotic Stenosis of the Middle Cerebral Artery: Analysis of 278 Continuous Cases.
    Zhao T; Zhu WY; Xiong XY; Li J; Wang L; Ding HY; Wei F; Zhou Y; Gong ZL; Cheng SY; Liu Y; Shuai J; Yang QW
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2368-72. PubMed ID: 27324301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients.
    Feng Z; Duan G; Zhang P; Chen L; Xu Y; Hong B; Zhao W; Liu J; Huang Q
    BMC Neurol; 2015 Oct; 15():187. PubMed ID: 26449986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial stenting of subacute symptomatic atherosclerotic occlusion versus stenosis.
    Lü PH; Park JW; Park S; Kim JL; Lee DH; Kwon SU; Kim JS; Yun SC; Suh DC
    Stroke; 2011 Dec; 42(12):3470-6. PubMed ID: 21940974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo pseudoaneurysm formation after angioplasty and stenting of posterior circulation intracranial atherosclerotic disease: mechanism, characterization with intravascular ultrasound and management considerations.
    Dabus G; Linfante I; Samaniego EA
    J Neurointerv Surg; 2013 Sep; 5(5):447-51. PubMed ID: 22892180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.